The two tumor cell lines, Caki2 and U87, tended to show similar results for several of the genes tested: ECOP, MGLL, and MAN1B. Our study showed that knockdown of these genes sensitized both Caki2 and U87 cells to mTOR inhibitors. The gene discussed is MAN1A2; the disease is neoplasm.